Royalty Pharma
RPRX
$28.16
Share price
0.97%
Change (1 day)
-21.54%
Change (1 year)
Categories
EPS for Royalty Pharma (RPRX)
EPS in 2023 (TTM): $0.55
According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is $0.55. In 2022 the company made an earnings per share (EPS) of $0.10000 a decrease over its 2021 EPS that were of $1.50.
EPS history for Royalty Pharma from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.55 | 450% |
| 2022 | $0.10000 | -93.33% |
| 2021 | $1.50 | -1.33% |
| 2020 | $1.52 | -77.07% |
| 2019 | $6.63 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $2.97 | 440.40% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 887.14% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -$0.47 | -185.45% | 🇺🇸 USA |